Amrize (NYSE:AMRZ) Downgraded by Wall Street Zen to “Sell”

Amrize (NYSE:AMRZ) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday, Wall Street Zen reports.

AMRZ has been the topic of several other reports. UBS Group dropped their target price on Amrize from $57.00 to $42.00 and set a “neutral” rating on the stock in a research report on Tuesday, September 22nd. Wells Fargo & Company cut their target price on Amrize from $40.00 to $39.00 and set an “equal weight” rating for the company in a research note on Friday, October 30th. JPMorgan Chase & Co. lowered their price objective on Amrize from $52.00 to $48.00 and set a “neutral” rating for the company in a research note on Tuesday, October 13th. Truist Financial decreased their price objective on Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a report on Monday, October 5th. Finally, William Blair set a $40.00 price objective on shares of Amrize in a report on Wednesday, September 2nd. Eight equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $49.06.

Amrize Stock Down 1.8%

AMRZ stock opened at $41.90 on Friday. Amrize has a 52-week low of $35.78 and a 52-week high of $65.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67. The stock has a market capitalization of $23.17 billion, a price-to-earnings ratio of 18.96, a price-to-earnings-growth ratio of 1.68 and a beta of 0.04. The company has a 50-day moving average of $39.53 and a two-hundred day moving average of $50.30.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.05. The company had revenue of $3.77 billion for the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. During the same period in the previous year, the company earned $0.98 earnings per share. Amrize’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Amrize will post 2.30 EPS for the current year.

Insiders Place Their Bets

In other Amrize news, CFO Baris Oran bought 3,000 shares of Amrize stock in a transaction on Tuesday, August 11th. The stock was purchased at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the purchase, the chief financial officer directly owned 3,000 shares of the company’s stock, valued at $142,140. The trade was a ? increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jacques Sanche bought 4,150 shares of the stock in a transaction on Wednesday, August 26th. The stock was purchased at an average cost of $45.02 per share, with a total value of $186,833.00. Following the purchase, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This represents a 73.90% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders purchased 48,983 shares of company stock valued at $2,158,755. 0.54% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. ProVise Management Group LLC lifted its position in Amrize by 11.3% during the 3rd quarter. ProVise Management Group LLC now owns 164,358 shares of the company’s stock worth $6,145,000 after acquiring an additional 16,642 shares during the period. Moors & Cabot Inc. lifted its stake in Amrize by 46.0% in the 3rd quarter. Moors & Cabot Inc. now owns 29,600 shares of the company’s stock valued at $1,107,000 after purchasing an additional 9,323 shares during the last quarter. Narwhal Capital Management boosted its position in Amrize by 23.8% during the 3rd quarter. Narwhal Capital Management now owns 81,263 shares of the company’s stock worth $3,038,000 after buying an additional 15,618 shares during the period. DMKC Advisory Services LLC lifted its holdings in Amrize by 11.3% during the third quarter. DMKC Advisory Services LLC now owns 75,488 shares of the company’s stock worth $2,823,000 after acquiring an additional 7,656 shares during the period. Finally, Pictet Asset Management Holding SA raised its position in Amrize by 4.3% in the 3rd quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company’s stock worth $230,110,000 after purchasing an additional 253,512 shares during the period.

Amrize Company Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.